Anthropometric measures after Fontan procedure: implications for suboptimal functional outcome
- PMID: 21146663
- PMCID: PMC3058397
- DOI: 10.1016/j.ahj.2010.07.039
Anthropometric measures after Fontan procedure: implications for suboptimal functional outcome
Abstract
Background: Abnormal height and adiposity are observed after the Fontan operation. These abnormalities may be associated with worse functional outcome.
Methods: We analyzed data from the National Heart, Lung, and Blood Institute Pediatric Heart Network cross-sectional study of Fontan patients. Groups were defined by height (z-score<-1.5 or≥-1.5) and body mass index (body mass index [BMI] z-score<-1.5 or -1.5 to 1.5 or≥1.5). Associations of anthropometric measures with measurements from clinical testing (exercise, echocardiography, magnetic resonance imaging) were determined adjusting for demographics, anatomy, and pre-Fontan status. Relationships between anthropometric measures and functional health status (FHS) were assessed using the Child Health Questionnaire.
Results: Mean age of the cohort (n=544) was 11.9±3.4 years. Lower height-z patients (n=124, 23%) were more likely to have pre-Fontan atrioventricular valve regurgitation (P=.029), as well as orthopedic and developmental problems (both P<.001). Lower height-z patients also had lower physical and psychosocial FHS summary scores (both P<.01). Higher BMI-z patients (n=45, 8%) and lower BMI-z patients (n=53, 10%) did not have worse FHS compared to midrange BMI-z patients (n=446, 82%). However, higher BMI-z patients had higher ventricular mass-to-volume ratio (P=.03) and lower % predicted maximum work (P=.004) compared to midrange and lower BMI-z patients.
Conclusions: Abnormal anthropometry is common in Fontan patients. Shorter stature is associated with poorer FHS and non-cardiac problems. Increased adiposity is associated with more ventricular hypertrophy and poorer exercise performance, which may have significant long-term implications in this at-risk population.
Trial registration: ClinicalTrials.gov NCT00132782.
Copyright © 2010 Mosby, Inc. All rights reserved.
Figures
References
-
- Gentles TL, Gauvreau K, Mayer JE, et al. Functional outcome after the Fontan operation: Factors influencing late morbidity. J Thorac Cardiovasc Surg. 1997;114:392–403. - PubMed
-
- Gelatt M, Hamilton RM, McCrindle BW, et al. Risk factors for atrial tacharrhythmias after the Fontan operation. J Am Coll Cardiol. 1994;24:1735–41. - PubMed
-
- van den Bosch AE, Roos-Hesselink JW, van Domburg R, et al. Long-term outcome and quality of life in adult patients after the Fontan operation. Am J Cardiol. 2004;93:1141–45. - PubMed
-
- Khairy P, Fernandes SM, Mayer JE, et al. Long-term survival, modes of death and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117:85–92. - PubMed
-
- Mertens L, Hagler DJ, Sauer U, et al. Protein-losing enteropathy after the Fontan operation: An International multicenter study. J Thorac Cardiovasc Surg. 1998;115:1063–73. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- HL068288/HL/NHLBI NIH HHS/United States
- HL068285/HL/NHLBI NIH HHS/United States
- U01 HL068269/HL/NHLBI NIH HHS/United States
- U01 HL068279/HL/NHLBI NIH HHS/United States
- U01 HL068290/HL/NHLBI NIH HHS/United States
- U10 HL068270/HL/NHLBI NIH HHS/United States
- U01 HL068281/HL/NHLBI NIH HHS/United States
- U01 HL068270/HL/NHLBI NIH HHS/United States
- HL068290/HL/NHLBI NIH HHS/United States
- HL068279/HL/NHLBI NIH HHS/United States
- U01 HL068288/HL/NHLBI NIH HHS/United States
- HL068281/HL/NHLBI NIH HHS/United States
- U01 HL068292/HL/NHLBI NIH HHS/United States
- HL068269/HL/NHLBI NIH HHS/United States
- HL068270/HL/NHLBI NIH HHS/United States
- U01 HL068285/HL/NHLBI NIH HHS/United States
- HL068292/HL/NHLBI NIH HHS/United States
